REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC - AMENDMENT
04/11/2020 07:10
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201104:nBw5RJDsda
Form 8.3 - WILLIS TOWERS WATSON PLC - AMENDMENT
Ap19
FORM 8.3 - Amendment to Purchase and Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 30 October 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,908,791 2.26% 464,039 0.36%
(2) Derivatives (other than options):
412,656 0.32% 744,751 0.58%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
3,321,447 2.58% 1,208,790 0.94%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 4 182.1975 USD
Purchase 6 182.0600 USD
Purchase 8 181.9350 USD
Purchase 8 183.0725 USD
Purchase 8 182.1850 USD
Purchase 8 182.1950 USD
Purchase 14 183.0435 USD
Purchase 15 182.6533 USD
Purchase 16 182.0993 USD
Purchase 20 182.4890 USD
Purchase 20 182.2895 USD
Purchase 38 183.0460 USD
Purchase 46 182.3460 USD
Purchase 50 182.5778 USD
Purchase 52 182.6880 USD
Purchase 54 182.7637 USD
Purchase 58 182.7703 USD
Purchase 68 182.8454 USD
Purchase 81 182.1441 USD
Purchase 85 182.3500 USD
Purchase 87 181.6610 USD
Purchase 110 185.3807 USD
Purchase 142 182.1138 USD
Purchase 159 183.1144 USD
Purchase 200 182.8600 USD
Purchase 201 184.0681 USD
Purchase 227 183.2430 USD
Purchase 320 182.5541 USD
Purchase 336 182.6573 USD
Purchase 386 183.4309 USD
Purchase 657 182.4823 USD
Purchase 676 182.3392 USD
Purchase 978 185.7751 USD
Purchase 1,360 180.8046 USD
Purchase 2,520 182.2376 USD
Purchase 3,000 181.4176 USD
Purchase 3,576 182.9388 USD
Purchase 3,604 182.1929 USD
Purchase 4,622 182.8752 USD
Purchase 7,226 182.4831 USD
Purchase 7,266 181.5583 USD
Purchase 9,696 182.3505 USD
Purchase 11,236 182.4800 USD
Purchase 12,899 181.9097 USD
Purchase 15,604 181.9103 USD
Purchase 17,400 184.2500 USD
Purchase 100,000 186.4000 USD
Purchase 163,869 185.0153 USD
Sale 1 184.0450 USD
Sale 4 181.7025 USD
Sale 6 181.6466 USD
Sale 8 182.0825 USD
Sale 9 181.6200 USD
Sale 13 185.9230 USD
Sale 85 183.8000 USD
Sale 141 181.8700 USD
Sale 200 180.5850 USD
Sale 247 181.9974 USD
Sale 290 182.5035 USD
Sale 300 180.8000 USD
Sale 511 181.0477 USD
Sale 625 186.5648 USD
Sale 655 186.0900 USD
Sale 740 182.6368 USD
Sale 751 180.7390 USD
Sale 832 180.9536 USD
Sale 891 181.7746 USD
Sale 1,166 182.0067 USD
Sale 1,350 180.6931 USD
Sale 1,360 180.8046 USD
Sale 2,118 181.0938 USD
Sale 2,637 183.3772 USD
Sale 2,802 180.4097 USD
Sale 3,668 180.7324 USD
Sale 4,792 182.4800 USD
Sale 5,443 181.9735 USD
Sale 5,621 181.9985 USD
Sale 7,112 182.4786 USD
Sale 8,921 182.5670 USD
Sale 13,362 181.8051 USD
Sale 13,446 182.3415 USD
Sale 20,000 184.2241 USD
Sale 20,000 181.8821 USD
Sale 67,400 185.8449 USD
Sale 82,360 185.0153 USD
Sale 100,000 186.4000 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing
and any other person relating to the voting rights of any relevant securities under any option
referred to on this form or relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is referenced. If none, this
should be stated.
NONE
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 4 Nov 2020
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201103005829/en/
(https://www.businesswire.com/news/home/20201103005829/en/)
BARCLAYS PLC
Copyright Business Wire 2020Recent news on Barclays
See all newsREG - DCC PLC Barclays PLC - Holding in Company TR-1
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC Unite Group PLC - Form 8.3 UNITE GROUP PLC, THE
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 - SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC Bakkavor Group PLC - Form 8.3 BAKKAVOR GROUP PLC
Announcement